BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hicar MD. Antibodies and Immunity During Kawasaki Disease. Front Cardiovasc Med 2020;7:94. [PMID: 32671098 DOI: 10.3389/fcvm.2020.00094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 McMurray JC, May JW, Cunningham MW, Jones OY. Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment. Front Pediatr 2020;8:626182. [PMID: 33425823 DOI: 10.3389/fped.2020.626182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
2 Hara T, Yamamura K, Sakai Y. The up-to-date pathophysiology of Kawasaki disease. Clin Transl Immunology 2021;10:e1284. [PMID: 33981434 DOI: 10.1002/cti2.1284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kostoff RN, Calina D, Kanduc D, Briggs MB, Vlachoyiannopoulos P, Svistunov AA, Tsatsakis A. Why are we vaccinating children against COVID-19? Toxicol Rep 2021;8:1665-84. [PMID: 34540594 DOI: 10.1016/j.toxrep.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Krishnan A, Gangadaran P, Chavda VP, Jogalekar MP, Muthusamy R, Valu D, Vadivalagan C, Ramani P, Laishevtcev A, Katari NK, Ahn BC. Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery. Exp Biol Med (Maywood) 2022;:15353702221092984. [PMID: 35549570 DOI: 10.1177/15353702221092984] [Reference Citation Analysis]
5 Hobbs CV, Khaitan A, Kirmse BM, Borkowsky W. COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes. Front Pediatr 2020;8:593455. [PMID: 33330288 DOI: 10.3389/fped.2020.593455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Chang AJ, Baron S, Hoffman J, Hicar MD. Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease. Mol Immunol 2022;145:67-77. [PMID: 35303530 DOI: 10.1016/j.molimm.2022.03.011] [Reference Citation Analysis]
7 Moody R, Wilson K, Flanagan KL, Jaworowski A, Plebanski M. Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci 2021;22:8965. [PMID: 34445670 DOI: 10.3390/ijms22168965] [Reference Citation Analysis]